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Stigma and Therapy Completion for Latent 
Tuberculosis among Haitian-origin Patients  
 
 
Jeannine Coreil, PhD, Michael Lauzardo, MD, Heather Clayton, MPH 
 
ABSTRACT 
A prospective cohort study of LTBI treatment conducted within the Haitian population of South Florida investigated 
the predictive association between illness-related stigma among patients near the beginning of treatment and 
completion of preventive therapy. Factors associated with perceived stigma were also investigated. Ninety patients 
from Broward and Palm Beach counties were administered a questionnaire that included items related to illness 
history, perceptions and understanding of latent tuberculosis, and a 25-item stigma scale adapted from previously 
developed measures of tuberculosis-related stigma. Therapy completion was determined through a follow-up chart 
review. Data analyses compared patients who completed therapy with those who defaulted on a number of variables 
including perceived stigma. No association was found between perceived stigma or demographic characteristics 
and adherence to preventive therapy. Perceived stigma was associated with patient report of illness-related distress 
and was higher among patients who were lost to follow up.  Some evidence suggested that stigma was higher among 
contacts of cases, patients with limited understanding of the condition, and patients who were more closely 
monitored during treatment. Case management should focus on patient-centered approaches to education and 
counseling about LTBI that address patient understanding of the condition and concerns about its physical and 
psychosocial effects. 
Florida Public Health Review, 2010; 7, 32-38. 
 
Introduction 
This study investigated the predictive association 
between tuberculosis-related stigma and completion 
of preventive therapy for latent tuberculosis infection 
(LTBI).  We tested the hypothesis that perceived 
stigma is negatively associated with adherence to 
LTBI treatment through a cohort study of latent TB 
patients of Haitian origin in Florida. 
Completion rates for treatment of LTBI are 
consistently low across diverse populations (Bieberly 
& Ali, 2008; Hirsch-Moverman, Daftary, Franks, & 
Colson, 2008; Pina-Gutierrez, Ferrer-Traid, Arias, 
Sala-Farre, & Lopez-Sanmartin, 2008).  A recent 
review of 78 studies found inconsistent associations 
between adherence and patient factors, clinic 
facilities, treatment characteristics and interventions 
to increase adherence (Hirsch-Moverman, et al., 
2008).  Researchers have suggested that social stigma 
may deter therapy completion among active 
tuberculosis patients (Macq, Solis, & Martinez, 
2006), however we found no published studies that 
investigated stigma related to LTBI or the influence 
of patient-perceived stigma on completion of therapy. 
In recent years public health attention to 
tuberculosis has been increasingly focused on 
immigrant groups that are disproportionately affected 
by the disease (Cain, Benoit, Winston, & MacKenzie, 
2008).  In South Florida, Haiti is the most common 
birth country (34.3%) among immigrants diagnosed 
with TB (Talbot, Moore, McCray, & Binkin, 2000).  
Between 1993 and 1998, the case rate for active 
tuberculosis among Haitians living in the U.S. was 
118.5 per 100,000 persons per year (Talbot, Moore, 
McCray, & Binkin (2000). Haitians make up only 2% 
of the state’s population, but accounted for 15% of all 
active cases of TB during the time of our study. A 
retrospective chart and database review in 2000 of 
reported cases of LTBI in Haitians living in Florida 
found 38% of Haitians completed therapy, compared 
to a 60% completion rate for all others on therapy for 
LTBI (Lauzardo, Duncan, Szwed, Narita, & Hale, 
2001). 
The potential for TB-related stigma to be of 
concern within the Haitian population is noteworthy 
because of deeply-rooted prejudice and negative 
stereotypes of the Haitian population in American 
society (Farmer, 1992; Granich et al., 1998; 
Nachman, 1993). The legacy of labeling Haitians as a 
risk group for HIV/AIDS in the 1980s continues to 
negatively impact public perceptions as well as 
within-group perceptions of community attitudes 
towards this population (Coreil, Lauzardo, & 
Heurtelou, 2004; Stepick, 1998).  Moreover, the 
resurgence of TB in recent years is associated with 
the AIDS epidemic.  For these reasons, strong 
perceptions of stigma related to tuberculosis would 
be expected in this population. 
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Study Population and Methods 
The adherence cohort study conducted in Florida 
was part of a larger cultural epidemiologic study of 
stigma and tuberculosis in Haitian populations 
residing in Haiti and the USA. Patients were adults 
diagnosed with latent TB infection (PPD+ skin test, 
but x-ray negative and asymptomatic) who began 
preventive therapy through the Broward County 
Health Department or the Palm Beach County Health 
Department.  In Florida, passive surveillance 
programs for TB are in place at public clinics that 
serve high-risk groups.  Screening is offered to 
Haitians, other foreign born individuals, and others 
with risk factors for progressing to active disease 
who access all health department clinics and services, 
and approximately half of patients offered the 
treatment accept to begin therapy.  First line 
recommended therapy is daily doses of isoniazid 
(INH) for a period of 9 months, if there are no 
contraindications. 
Ethical oversight of the study was reviewed by 
the Institutional Review Boards of the University of 
South Florida, the University of Florida and the 
Florida Department of Health.  All study participants 
gave informed consent to take part in the study. 
A total of 90 patients were enrolled in the 
adherence study over a two year period (August 
2005-July 2007), 63 from Broward County and 27 
from Palm Beach County. Demographic 
characteristics of the sample are presented in Table 2.  
The primary outcome measure of adherence was 
completion of therapy.  Adherence to the prescribed 
therapeutic regimen is monitored through monthly 
follow-up appointments where patients come in for a 
check-up and to receive a month’s supply of 
medication.  High risk patients, including children 
and HIV co-infected persons, are monitored through 
directly observed preventive therapy (DOPT). 
Follow-up data on treatment completion were 
extracted from patient records.  Treatment adherence 
was measured by a dichotomous variable (complete 
vs. default) and analyzed in relation to several 
independent variables including stigma score, 
accurate understanding of the condition, perceived 
cause, reported distress, participation in DOPT, 
county of residence and socio-demographic variables.  
Study variables were measured through an 
interviewer-administered questionnaire called the 
EMIC for Tuberculosis in Haitian Populations, 
adapted from a similar instrument developed for a 
multi-country study of tuberculosis and gender 
(Weiss et al., 2008). Development of the stigma scale 
began with a core set of items used in previous 
studies of stigma, including items related to internal 
perceptions and emotions, disclosure,  external 
perceptions, external actions, and courtesy stigma 
(effects on significant others).  Based on local 
validation procedures and previous ethnographic 
research (Coreil, Lauzardo, & Heurtelou, 2004), two 
items were added to the scale related to patients 
feeling greater stigma because they were Haitian. Out 
of 34 items in the stigma scale, 9 were deleted 
because they showed weak correlations with the other 
items in the scale.  The final scale (Table 1) consisted 
of 25 items with good internal consistency (α = .87).  
Coding of responses for the Stigma Scale ranges 
from 0-3 (0 for “no,” 1 for “uncertain,” 2 for 
“possibly,” and 3 for “yes”). A composite stigma 
score is computed by adding scores for each item.     
 
Results 
Overall level of perceived stigma was low, with 
a mean score of 25.1 for the total patient sample 
(maximum possible score of 100).  The majority of 
patients responded “No” to most scale items, with the 
exception of items related to disclosure of one’s 
diagnosis to others.  Most participants (76-92%) 
indicated they would not discuss their condition with 
people outside the family (friends, neighbors, co-
workers, church members, others), and about half 
(51%) would not discuss it with family members 
Of the 90 LTBI patients, 67 (74.4%) had chart-
documented completion of therapy, 5 (5.5%) 
discontinued therapy because of medical advice, and 
18 (20.0%) were categorized as “defaulters.”  Within 
the defaulter group, 5 had chart-documented 
voluntary withdrawal from therapy and 13 were 
considered “lost to follow-up” because they moved, 
could not be located, or no information was found in 
their charts regarding completion. No significant 
differences in therapy completion rates were found 
by county, socio-demographic characteristics, referral 
source, participation in DOPT, perceived cause or 
patient understanding of the condition.  However, it 
is noteworthy that only the HIV co-infection group, 
all of which received DOPT, had 100% completion 
rates.  No significant differences in mean stigma 
scores were found across therapy completion groups, 
categorized various ways.  Likewise, no group 
differences were found when individual items in the 
stigma scale were analyzed separately.  
Comparison of stigma scores between the 
treatment completion group and the defaulter group 
showed they were almost identical (24.9, 25.0).  
However when defaulters in the “moved or lost to 
follow-up” group (N = 6) were compared to other 
defaulters, significant differences in stigma scores 
were found.  The “moved or lost to follow-up” group 
had a mean stigma score of 36.3 compared to a mean 
score of 21.6 for other defaulters (t = 2.65, df = 21, p 
= .015). 
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Table 1.  Stigma Scale Items 
 
Internal Perceptions and Emotions 
1. Do you think less of yourself because of this problem?  Has it reduced your pride or self-respect? 
2. Have you ever been made to feel shamed or embarrassed because of this problem, or are you concerned that 
this might happen? 
Disclosure 
3. If possible, would you prefer to keep people from knowing about this problem? 
4. Have you discussed or do you plan to discuss this problem with the person you consider closest to you, the 
one whom you usually feel you can talk to the most easily? 
5. Have you discussed or do you plan to discuss this with neighbors? 
6. Have you discussed or do you plan to discuss this with co-workers? 
External Perceptions 
7. Do your neighbors, colleagues or others in your community have less respect for you because of this 
problem, or do you think they would if they knew about it? 
8. If they knew about it, would your neighbors, colleagues or others in your community think less of your 
family because of this problem? 
9. Even if you don’t (or didn’t) have any other health problems, are people likely to think you do because of 
your TB germ/disease? 
10. Are you worried that people will assume you have HIV? 
11. Are you concerned that others will assume that you have the real TB disease? 
External Actions 
12. (If unmarried) Do you feel that even after your condition is cured, it might still make it difficult for you to 
marry? (If married) If you were unmarried, do you feel that this condition would have made it difficult for 
you to marry, even after it was cured? 
13. Do you feel others have avoided or might avoid you because of this problem? 
14. Would some people refuse to visit your home because of this condition even after you have been treated? 
15. Have you been asked to stay away from work or social groups, or are you concerned that if people knew 
about it, that you might be asked to stay away even after treatment? 
16. Might you decide on your own to stay away from work or social groups? 
17. (If unmarried) If you were married, do you think your spouse might refuse sex with you because of the 
problem? (If married) Has your spouse refused sex or might refuse sex with you because of the problem? 
18. (If unmarried) If you were married, do you feel that this condition would cause other problems in your 
marriage even after it was cured? (If married) Do you feel that even after it is cured, that this condition will 
create other problems in your marriage? 
19. Now that you have this problem, do you think that your parents and siblings (or children)/parental family will 
provide or have provided adequate support? 
20. Should your parents and siblings (or children)/parental family have done more to help you? 
Courtesy Stigma 
21. Might contact with you have any bad effects on others around you even after you have been treated? 
22. (If patient has children) Do you feel that your condition might cause social problems for your children in the 
community? (If no children) If you had children, do you feel that your condition might cause social problems 
for them in the community? 
23. Do you feel that this disease might make it more difficult for someone else in your family to marry? 
Haitian Identity 
24. Is it more embarrassing for you to have a TB-related condition because you are Haitian than it would be for 
other people in Florida? 
25. Because you are Haitian will people think worse of you than others with the same TB condition? 
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Table 2.  Demographic Characteristics of Patients 
 
Given that LTBI is a condition diagnosed in the 
absence of symptoms, it is not surprising that a 
majority of these patients (61.1%) reported that they 
experienced no forms of distress associated with the 
disease.  When the no-distress patients were 
compared on stigma scores with those who reported 
some form of distress (physical, psychosocial, 
economic, medication side effects), a significantly 
lower mean stigma score was found (20.5 vs. 32.2, p 
= .003). 
Table 3 presents stigma scores in relation to 
referral source - that is, how a patient came to be 
diagnosed with LTBI, including contacts of active 
TB cases, HIV co-infection, work screening, school 
screening, refugee clinic, recent arrival and other 
sources.  The highest mean stigma score was found 
among contacts of cases (31.2), and the lowest score 
was found among patients screened for employment 
(14.2).  Stigma scores for patients in each category 
were compared to all others.  Contacts of TB cases 
had higher stigma scores compared to all others (31.2 
vs. 23.3), although this difference had borderline 
statistical significance (p = .059). 
Table 4 presents stigma scores by patients’ 
understanding of their condition (“How would you 
describe the condition for which you are being 
treated?”).  About half the patients identified the “TB 
germ,” the local term for LTBI in Haitian Creole.  
About 10% each identified the BCG vaccine, denied 
having any condition, or did not know.  About 5% 
said they had TB disease.  Patients who rejected the 
diagnosis of a medical condition had the highest 
mean stigma score (32.7), while those who correctly 
identified the TB germ had the lowest (22.7).  Due to 
the small sample sizes and large variances across 
categories these differences were not statistically 
significant.  It is noteworthy that patients who 
correctly identified the nature of their condition (“TB 
germ”), and those who identified the BCG vaccine, 
which is closely associated with “TB germ” in this 
population, there was markedly greater consistency in 
stigma scores, as reflected in lower variances. 
Significant differences were found in patient 
stigma scores by county.  The mean score for 
Broward County was significantly higher (29.3) than 
that for Palm Beach County (15.1) (t=5.2, df = 84, p 
< .0001).  Comparison of socio-demographic 
characteristics by county showed no differences in 
gender, education, income, or employment status, 
however patients from Palm Beach County on 
average had resided in the U.S. longer, were older, 
and proportionately more were widowed and 
Protestant. None of the latter socio-demographic 
differences were associated with stigma scores or 
adherence rate. 
Closer examination of the defaulted patients was 
conducted based on their interviews and medical 
records, including demographic profile, illness 
history, responses to key questions, and narrative 
commentary provided to selected questions.  It is 
interesting that all of the defaulters indicated that 
they intended to complete therapy when interviewed 
near the beginning of their treatment.  Like other 
LTBI patients, they identified a variety of possible 
causes of their conditions, including in rank order 
diet, malnutrition, airborne exposure, constitutional 
weakness, water, physical exertion, humoral 
imbalance, BCG vaccine, germs/infection/contagion, 
sanitation, sexual contact, and a hard life, indicating 
that there is limited understanding of the ways in 
which people acquire latent TB, and the difference 
between latent and active TB. 
 
Discussion  
Overall low levels of stigma were associated 
with latent TB infection in this population, however 
strong reluctance to disclose one’s condition to 
others, including family members, was found. 
    N %
  
 
Female    54 60.0 
Palm Beach   27 30.0 
Broward    63 70.0 
Marital status: 
 Single   31 33.3 
 Married/partnered 53 58.9 
 Divorced/widowed   6   6.7 
Employment 
 Full-time  46 51.1 
 Part-time  21 23.3 
 Unemployed  22 24.4 
Religion 
 Protestant  49 54.4 
 Catholic   27 30.0 
 Other   14 15.6 
Literacy (yes)   79 87.8 
Interview in Creole  86 95.6 
Education 
 8 yrs or less  18 20.0 
 9-11 years  20 22.2 
 12 years   19 21.1 
 12 years  23 25.5 
Missing   10 11.1 
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Table 3.  Stigma Scores by Referral Source 
Referral source*   Frequency (%)  Stigma score  t-test vs. all others 
Contact of case 20 (22.2) 31.2 .058 
HIV co-infection   7 (7.8) 26.1 NS 
Work screening   3 (3.3) 14.2 NS 
School screening   3 (3.3) 30.0 NS 
Refugee clinic 32 (3.3) 22.1 NS 
Recent arrival   3 (3.3) 30.0 NS 
Other referral 13 (14.4) 22.8 NS 
*Missing = 9  
 
Table 4.  Stigma Scores by Patient Description of Condition 
LTBI description by patient  N (%)          Mean stigma          SD 
TB germ 50 (55.6) 22.7 10.4 
BCG vaccine  9 (10.0) 23.5   7.4 
Reject diagnosis  9 (10.0) 32.7 21.8 
Don’t know/not told 10 (11.1) 26.7 23.8 
TB disease   5 (5.6) 29.8 34.4 
Other   7 (7.8) 28.1 24.4 
 
 
Moreover, the findings do not support an association 
between patient-perceived stigma and completion of 
therapy for LTBI. Therapy completion was not 
associated with treatment facility, socio-demographic 
characteristics, referral source, participation in 
DOPT, perceived cause, or patient understanding of 
the condition. There was some evidence that 
completion was higher among HIV co-infected 
patients, but small sample size in the defaulter group 
limits interpretation of this finding. 
The rates of therapy for LTBI completion found 
in this study were notably higher than what has been 
reported for other populations as well as in a previous 
statewide study of Florida’s Haitian population 
(Lauzardo, Duncan, Szwed, Narita, & Hale, 2001).  
Self-selection bias may have excluded patients most 
likely to default.  Only patients who had begun 
therapy were included in the study, eliminating 
patients who refused treatment altogether. It is 
possible that patients who felt the most stigma related 
to their diagnosis, and were therefore more likely to 
default, were excluded from the study. Refusers often 
denied having any TB related condition, and did not 
want to have anything to do with a study of 
tuberculosis. In addition, study participants were 
recruited during the first month of treatment, and 
there is evidence that adherence during the first 
month of treatment is predictive of therapy 
completion (Menzies et al., 2005).  However, therapy 
completion rates did not differ by county, despite 
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differences in refusal rate and stigma scores, as 
discussed further below. 
Perceived stigma was higher among patients 
reporting some form of distress associated with 
LTBI, and among defaulters categorized as “lost to 
follow-up.” Contacts of cases and patients who 
misunderstood the nature of their diagnosis scored 
higher on stigma, although not statistically 
significant.  Nevertheless, it is noteworthy that 44% 
of participants did not have a good understanding 
about the nature of the condition, including 11% who 
said they didn’t know what they had or were not told 
anything about the condition.  
The higher stigma scores found among patients 
in Broward County compared to Palm Beach County 
may be attributed to at least two factors, the high 
refusal rate in Palm Beach County for participation in 
the study, and differences in county TB Programs.  
The refusal rate was 60% in Palm Beach County but 
only 15% in Broward County.  It is possible that 
refusers felt greater stigma related to their diagnoses 
and therefore the Palm Beach participants were self-
selected for lower stigma.  Programmatic differences 
between counties also may have influenced 
differences in perceived stigma as well as participant 
recruitment.  The main difference between counties is 
the organization of their Tuberculosis Programs.  
Broward County, for a variety of reasons had been 
able to garner more resources for their TB Program at 
the time of the study, and was therefore able to 
implement a higher level of supervision of LTBI 
patients, including more patients on DOT, than is the 
standard of care around the US.  The more intense 
interaction with patients in Broward may have 
influenced the presence of higher stigma scores as 
well as the higher rate of participation in the study.  
This is consistent with other studies which report 
higher perceived stigma among patients treated in 
closely monitored TB treatment programs (Weiss, 
Auer, Somma, & Abouihia, 2006).   
Research on the association between close 
supervision of therapy of LTBI and adherence is 
inconsistent.  Some studies have found higher 
completion rates among patients receiving DOPT 
(White, Gournis, Kawamura, Menendez, & Tulsky, 
2003), while others have found the reverse (Matelli et 
al., 2000).  Our study did not show an association 
between level of patient monitoring and treatment 
adherence.   
A limitation of the study was the small sample 
size of the defaulter patient group (N=18), which 
precluded multivariate analysis of results.  Bivariate 
analyses suggested that differences in stigma scores 
within subgroups of defaulters, such as by referral 
source and understanding of the condition, warrant 
further investigation in relation to therapy 
completion.  Stigma reduction among patients is 
itself an important clinical goal, and our findings 
suggest that patients who report illness-related 
distress and patients who are lost to follow up 
perceive higher illness-related stigma.  Results also 
highlight the need for effective patient counseling 
strategies to improve patient understanding of the 
causes and clinical aspects of latent TB infection, and 
to help patients make decisions about disclosure of 
the diagnosis to others (Ito, 2004).  The findings 
underscore the importance of a patient-centered 
approach to stigma reduction, which focuses on 
influencing intrapersonal factors of the illness 
experience (Heijnders & Van Der Meij, 2006).  In 
particular, early assessment of residential instability, 
patient comprehension and concerns about their 
diagnosis should be addressed in case management.   
 
Conclusion 
No association was found between perceived 
stigma and adherence to preventive therapy for LTBI 
in this study of Haitian origin patients in South 
Florida. There was some evidence that closer clinical 
supervision of LTBI patients increased perceptions of 
stigma in patients, but this did not affect therapy 
completion. The findings are consistent with previous 
studies which have been unable to identify clear 
predictors of therapy for LTBI completion. Perceived 
stigma was associated with patient report of illness-
related distress, and was higher among patients who 
were lost to follow up. The implications for clinical 
practice are that patient-centered approaches to 
education and counseling about LTBI should focus 
on patient understanding of the condition and 
concerns about its physical and psychosocial effects.  
 
Acknowledgements 
Support for the study was provided through grant no. 
1-R01-TW06320 from the NIH Fogarty International 
Center (2003-08). The authors appreciate the 
assistance of tuberculosis program staff in Broward 




Bieberly, J. & Ali, J. (2008). Treatment 
adherence of the latently infected tuberculosis 
population (post-Katrina) at Wetmore TB Clinic, 
New Orleans, USA.  International Journal of 
Tuberculosis and Lung Disease, 12(10), 1134-1138. 
Cain, K. P., Benoit, S. R., Winston, C. A. & 
MacKenzie, W. R. (2008). Tuberculosis among 
foreign-born persons in the United States.  Journal of 
the American Medical Association, 300(4), 405-412. 
Coreil, J., Lauzardo, M. & Heurtelou, M.  
(2004). Cultural feasibility assessment of tuberculosis 
6
Florida Public Health Review, Vol. 7 [2010], Art. 7
https://digitalcommons.unf.edu/fphr/vol7/iss1/7




control among persons of Haitian origin in South 
Florida.  Journal of Immigrant Health, 6(2), 63-69. 
Farmer, P. (1992).  AIDS and Accusation: Haiti 
and the Geography of Blame.  Berkeley: University 
of California Press. 
Granich, R.M., Zuber, P.L., McMillan, M., 
Cobb, J.D., Burr, J., Sfakianaki, E.D., et al. (1998).  
Tuberculosis among foreign-born residents of 
southern Florida, 1995.  Public Health Reports, 
113(6), 552-556. 
Heijnders, M. & Van Der Meij, S. (2006). The 
fight against stigma: An overview of stigma-
reduction strategies and interventions.  Psychology of 
Health and Medicine, 11(3), 353-363. 
Hirsch-Moverman, Y., Daftary, A., Franks, J. & 
Colson, P. W. (2008). Adherence to treatment for 
latent tuberculosis infection: Systematic review of 
studies in the US and Canada.  International Journal 
of Tuberculosis and Lung Disease, 12(11), 1235-
1254. 
Ito, K. (2004). Health culture and the clinical 
encounter: Vietnamese refugees’ responses to 
preventive drug treatment for inactive tuberculosis. 
Medical Anthropology Quarterly, 13(3), 338-364. 
Lauzardo, M., Duncan, H., Szwed, T., Narita, M. 
& Hale, Y. (2001). Tuberculosis among individuals 
of Haitian origin in Florida: Opportunities for 
intervention.  American Journal of Respiratory and 
Critical Care Medicine, 163(5) Part 2, A-100. 
Macq, J., Solis, A., & Martinez, G. (2006). 
Assessing the stigma of tuberculosis.  Psychology of 
Health and Medicine, 11(3), 346-352. 
Matteelli, A., Casalini, C., Raviglione, M. C., El-
Hamad, I., Scolari, C., Bombana, E., et al. (2000).  
Supervised preventive therapy for latent tuberculosis 
infection in illegal immigrants in Italy.  American 
Journal of Respiratory and Critical Care Medicine, 
162(5), 1653-1655. 
Menzies, D., Dion, M. J., Francis, D., Parisien, 
I., Rocher, I., Mannix, S. Et al. (2005).  In closely 
monitored patients, adherence in the first month 
predicts completion of therapy for latent tuberculosis 
infection.  International Journal of Tuberculosis and 
Lung Disease, 9(12), 1343-1348. 
Nachman, S.R. (1993). Wasted lives: 
Tuberculosis and other health risks of being Haitian 
in a U.S. detention camp. Medical Anthropology 
Quarterly, 7(3), 227-259. 
Pina-Gutierrez, J.M., Ferrer-Traid, A., Arias, C., 
Sala-Farre, M.R., & Lopez-Sanmartin, J.L. (2008).  
Adherence and effectiveness of the treatment of 
latent tuberculosis infection with isoniazid for 9 
months in a cohort of 755 patients.  Medicina 
Clinica, 130(5), 165-171. 
Stepick, A. (1998)  Pride against prejudice: 
Haitians in the United States.  Boston: Allyn & 
Bacon. 
Talbot, E.A., Moore, M., McCray, E., & Binkin, 
N.J. (2000). Tuberculosis among foreign-born 
persons in the United States, 1993-1998.  Journal of 
the American Medical Association, 284(22), 2894-
2899. 
Weiss, M.G., Auer, C., Somma, D.B. & 
Abouihia, A. (2006). Gender and tuberculosis: Cross-
site analysis and implications of a multi-country 
study in Bangladesh, India, Malawi and Colombia. 
UNICEF/UNDP/World Bank/ WHO, Special 
Program for Research and Training in Tropical 
Diseases (TDR), Social, Economic and Behavioural 




Weiss, M.G., Somma, D., Karim, F., Abouihia, 
A., Auer, C, Kemp, J. et al. (2008). Cultural 
epidemiology of TB with reference to gender in 
Bangladesh, India and Malawi. International Journal 
of Tuberculosis and Lung Disease, 12(7), 837-847. 
White, M.C., Gournis, E., Kawamura, M., 
Menendez, E., & Tulsky, J.P. (2003). Effect of 
directly observed preventive therapy for latent 
tuberculosis infection in San Francisco.  International 
Journal of Tuberculosis and Lung Disease, 7(1), 30-
35. 
 
Jeannine Coreil (jcoreil@health.usf.edu) is Professor of 
Social and Behavioral Science, Department of 
Community and Family Health, University of South 
Florida College of Public Health, Tampa, FL.  Michael 
Lauzardo (lauzam@medicine.ufl.edu) is Director of the 
Southeast National Tuberculosis Center, University of 
Florida, Gainesville, FL, and Deputy Tuberculosis 
Controller with the Florida Department of Health, 
Alachua County Health Department in Gainesville, FL. 
Heather Clayton (hclayton@health.usf.edu) is a 
Graduate Research Assistant and Doctoral Candidate, 
Department of Community and Family Health, 
University of South Florida College of Public Health, 
Tampa, FL. This paper was submitted to the FPHR on 
February 3, 2010, revised and resubmitted, and accepted 
for publication on March 25, 2010. Copyright 2010 by 
the Florida Public Health Review. 
7
Coreil et al.: Stigma and Therapy Completion for Latent Tuberculosis among Haiti
Published by UNF Digital Commons, 2010
